医生和制药公司：多年来依旧关系密切。
Doctors and drug companies: still cozy after all these years.
机构信息
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
出版信息
PLoS Med. 2010 Nov 2;7(11):e1000359. doi: 10.1371/journal.pmed.1000359.
Abstract
Geoff Spurling and colleagues report findings of a systematic review looking at the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. They fail to find evidence of improvements in prescribing after exposure, and find some evidence of an association with higher prescribing frequency, higher costs, or lower prescribing quality.
摘要
杰弗里·斯珀林（Geoff Spurling）及其同事报告了一项系统评价的研究结果，该评价旨在研究接触制药公司的促销材料与处方的质量、数量和费用之间的关系。他们没有发现接触后处方改进的证据，反而发现了一些与更高的处方频率、更高的成本或更低的处方质量有关的证据。
相似文献
1
Doctors and drug companies: still cozy after all these years.医生和制药公司：多年来依旧关系密切。
PLoS Med. 2010 Nov 2;7(11):e1000359. doi: 10.1371/journal.pmed.1000359.
2
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.来自制药公司的信息以及医生处方的质量、数量和成本：系统评价。
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
3
Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.学术医疗中心的药品推广：基于正确的理由、凭借正确的证据、在正确的时间进行规范。
Am J Bioeth. 2010 Jan;10(1):21-3. doi: 10.1080/15265160903441103.
4
Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.制药行业向医生推销阿片类产品与随后的阿片类药物处方之间的关联。
JAMA Intern Med. 2018 Jun 1;178(6):861-863. doi: 10.1001/jamainternmed.2018.1999.
5
Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.医药行业向泌尿科医生支付的促销款项与靶向治疗药物的处方模式。
Urology. 2021 Feb;148:134-140. doi: 10.1016/j.urology.2020.08.080. Epub 2020 Oct 16.
6
Conflicts of interest between the prescriber, the regulator and the profit maker.
Clin Microbiol Infect. 2001;7 Suppl 6:9-11.
7
Prescribing.开处方
Practitioner. 1990 Oct;234(1495):888-90.
8
Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.药企向医生支付报酬与更高的药物使用量和更昂贵的阿片类镇痛药处方有关。
PLoS One. 2018 Dec 19;13(12):e0209383. doi: 10.1371/journal.pone.0209383. eCollection 2018.
9
Financial incentives and the prescription of newer vaccines by doctors in India.印度医生的经济激励措施与新型疫苗的处方情况
Indian J Med Ethics. 2010 Jan-Mar;7(1):28-30. doi: 10.20529/IJME.2010.010.
10
No more free drug samples?不再有免费的药品样品了？
PLoS Med. 2009 May 5;6(5):e1000074. doi: 10.1371/journal.pmed.1000074. Epub 2009 May 12.
引用本文的文献
1
Differences in the information about procedures after cold chain disruption provided by pharmaceutical industry to hospital and community pharmacies.制药行业向医院药房和社区药房提供的冷链中断后程序信息的差异。
Eur J Hosp Pharm. 2016 Mar;23(2):96-99. doi: 10.1136/ejhpharm-2015-000723. Epub 2015 Sep 30.
2
Professionalism perspectives among medical students of a novel medical graduate school in Malaysia.马来西亚一所新型医学院校医学生的职业素养观点
Adv Med Educ Pract. 2016 Jul 25;7:407-22. doi: 10.2147/AMEP.S90737. eCollection 2016.
本文引用的文献
1
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.来自制药公司的信息以及医生处方的质量、数量和成本：系统评价。
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
2
Mandatory disclosure of pharmaceutical industry-funded events for health professionals.强制披露医药行业资助的医疗专业人员相关活动。
PLoS Med. 2009 Nov;6(11):e1000128. doi: 10.1371/journal.pmed.1000128. Epub 2009 Nov 3.
3
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.专业医学协会及其与行业的关系：关于控制利益冲突的提议。
JAMA. 2009 Apr 1;301(13):1367-72. doi: 10.1001/jama.2009.407.
4
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.引发利益冲突的医疗行业行为：针对学术医疗中心的一项政策提案
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.
5
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.紧密的联系：临床研究人员与制药行业之间的多重关系
Arch Intern Med. 2005 Nov 28;165(21):2493-6. doi: 10.1001/archinte.165.21.2493.
6
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.识别PubMed上随机试验中的结果报告偏倚：出版物综述与作者调查
BMJ. 2005 Apr 2;330(7494):753. doi: 10.1136/bmj.38356.424606.8F. Epub 2005 Jan 28.
7
Doctors and drug companies.医生和制药公司。
N Engl J Med. 2004 Oct 28;351(18):1885-90. doi: 10.1056/NEJMhpr042734.
8
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.披萨钱谁来付？重新定义医生与制药公司之间的关系。1：纠葛。
BMJ. 2003 May 31;326(7400):1189-92. doi: 10.1136/bmj.326.7400.1189.
9
10
Publication bias in clinical research.临床研究中的发表偏倚。
Lancet. 1991 Apr 13;337(8746):867-72. doi: 10.1016/0140-6736(91)90201-y.
Zotero 插件